Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie: = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Book |
| Language: | English |
| Published: |
Freiburg im Breisgau
[2021]
|
| Subjects: | |
| Online Access: | Inhaltsverzeichnis Inhaltsverzeichnis |
| Physical Description: | 65 Blätter Illustrationen, Diagramme 30 cm |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047335981 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 210617s2021 gw a||| m||| 00||| eng d | ||
| 015 | |a 21,H04 |2 dnb | ||
| 016 | 7 | |a 1226896227 |2 DE-101 | |
| 020 | |c Broschur | ||
| 035 | |a (OCoLC)1245375843 | ||
| 035 | |a (DE-599)KXP1747969346 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BW | ||
| 049 | |a DE-355 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Lerke, Frederik |e Verfasser |0 (DE-588)1226864422 |4 aut | |
| 245 | 1 | 0 | |a Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie |b = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |c vorgelegt 2020 von Frederik Lerke |
| 246 | 1 | 3 | |a Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| 246 | 1 | 1 | |a Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| 264 | 1 | |a Freiburg im Breisgau |c [2021] | |
| 300 | |a 65 Blätter |b Illustrationen, Diagramme |c 30 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Albert-Ludwigs-Universität Freiburg im Breisgau |d 2020 | ||
| 650 | 0 | 7 | |8 1\p |a Arterie |0 (DE-588)4003066-0 |2 gnd |
| 650 | 0 | 7 | |8 2\p |a Oberschenkelknochen |0 (DE-588)4172282-6 |2 gnd |
| 650 | 0 | 7 | |8 3\p |a Restenose |0 (DE-588)4254140-2 |2 gnd |
| 650 | 0 | 7 | |8 4\p |a Angioplastie |0 (DE-588)4134337-2 |2 gnd |
| 650 | 0 | 7 | |8 5\p |a Laserangioplastie |0 (DE-588)4201389-6 |2 gnd |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 856 | 4 | 2 | |m B:DE-101 |q application/pdf |u https://d-nb.info/1226896227/04 |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032738502&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032738502 | ||
| 883 | 0 | |8 1\p |a aepgnd |c 0,21112 |d 20210302 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 2\p |a aepgnd |c 0,17098 |d 20210302 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 3\p |a aepgnd |c 0,14789 |d 20210302 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 4\p |a aepgnd |c 0,14412 |d 20210302 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 5\p |a aepgnd |c 0,10975 |d 20210302 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
Record in the Search Index
| _version_ | 1804182549153447936 |
|---|---|
| adam_text | INDEX
1.
INTRODUCTION
..........................................................................................................
1
1.1
SUBJECT
MATTER
.........................................................................................................
1
1.2
PERIPHERAL
ARTERY
DISEASE
(PAD)
...........................................................................
1
1.2.1
DISEASE
OVERVIEW
.............................................................................................
1
1.2.2
ETIOLOGY
............................................................................................................
2
1.2.3
RISK
FACTORS
.....................................................................................................
2
1.2.4
PAD
AND
THE
SUPERFICIAL
FEMORAL
AND
POPLITEAL
ARTERY
.....................................
3
1.2.4.1
SUPERFICIAL
FEMORAL
ARTERY
AND
POPLITEAL
ARTERY
ANATOMY
...................................
4
1.2.4.2
ADDITIONAL
FACTORS
IN
THE
ONSET
AND
TREATMENT
OF
PAD
IN
THE
SFA
....................
4
1.2.5
THERAPY
............................................................................................................
5
1.2.5.1
REDUCTION
OF
RISK
FACTORS..................................................................................
5
1.2.5.2
DRUG
THERAPY
.....................................................................................................
6
1.2.5.3
EXERCISE
TRAINING
...............................................................................................
6
1.2.5.4
OPERATIONAL
/
BYPASS
THERAPY
...........................................................................
7
1.2.5.5
CATHETER-BASED
INTERVENTIONS
............................................................................
7
1.2.5.5.1
DRUG
COATED
BALLOON
...................................................................................
8
1.2.5.5.2
PHOTO-ABLATIVE
ATHERECTOMY
.........................................................................
8
1.3
CLASSIFICATION
SYSTEMS
USED
FOR
PAD
AND
IN-STENT
RESTENOSIS
.........................
9
1.3.1
FONTAINE
CLASSIFICATION.....................................................................................
9
1.3.2
RUTHERFORD-BECKER
CLASSIFICATION
.....................................................................
10
1.3.3
TASC
II
CLASSIFICATION
......................................................................................
11
1.3.4
TOSAKA
CLASSIFICATION
......................................................................................
11
2.
MATERIALS
AND
METHODS
....................................................................................
12
2.1
STUDY
DESIGN..........................................
12
2.2
STUDY
PURPOSE
.....................................................................................................
12
2.3
STUDY
OUTCOME
....................................................................................................
12
2.3.1
PRIMARY
OUTCOME
...........................................................................................
12
2.3.2
SECONDARY
OUTCOMES
....................................................................................
13
2.4
SELECTION
OF
PATIENTS
...........................................................................................
14
2.4.1
INCLUSION
/
EXCLUSION
CRITERIA..........................................................................
14
2.4.2
RANDOMIZATION...............................................................................................
15
2.5
PRE-PROCEDURE......................................................................................................
15
2.6
PROCEDURE
.............................................................................................................
16
2.6.1
TARGET
/
NON-TARGET
LESION............................................................................
16
2.6.2
EXCIMER
LASER
PHOTOABLATION
AND
DCB
GROUP
PROCEDURES............................
16
2.6.3
DCB
GROUP
PROCEDURES
..................................................................................
18
2.6.4
ADJUNCTIVE
PROCEDURES
....................................................................................
18
2.6.5
PROCEDURE
COMPLETION
....................................................................................
18
2.6.6
MEDICAL
ANTICOAGULANT
/
ANTIPLATELET
THERAPY
..................................................
18
2.6.7
FOLLOW-UP
REQUIREMENTS
.................................................................................
19
2.6.8
UNSCHEDULED
REINTERVENTION...........................................................................
19
2.6.9
TERMINATION
OF
PARTICIPATION
/
SUBJECT
WITHDRAWAL
.........................................
20
2.6.10
ADVERSE
EVENTS..............................................................................................
20
2.7
DATA
RECORDED
......................................................................................................
21
3.
RESULTS
...............................................................................................................
22
3.1
ENROLMENT
STATUS
.................................................................................................
22
3.2
PATIENT
CHARACTERISTICS........................................................................................
23
3.2.1
CARDIOVASCULAR
RISK
FACTORS
AT
BASELINE
.......................................................
24
3.2.2
COMORBIDITIES
AT
BASELINE
..............................................................................
25
3.3
LESION
CHARACTERISTICS
........................................................................................
26
3.3.1
PREVIOUS
TREATMENT
FOR
PAD
ON
TARGET
VESSEL
..............................................
27
3.3.2
LESION
CHARACTERISTICS:
DEGREE
OF
STENOSIS
PRE-TREATMENT............................
27
3.3.3
POST-TREATMENT
LESION
CHARACTERISTICS..........................................................
28
3.3.4
CALCIFICATION
OF
TARGET
VESSEL
AT
BASELINE
.....................................................
29
3.3.5
LESION
LENGTH
AT
BASELINE
.............................................................................
30
3.4
PROCEDURAL
VARIABLES
...........................................................................................
30
3.5
POST-PROCEDURAL
RESULTS
........................
31
3.5.1
PRIMARY
ENDPOINT
-
TARGET
LESION
PERCENT
STENOSIS
AT
1
YEAR
.......................
31
3.5.2
LATE
LUMEN
LOESS
AT
12
MONTHS
.....................................................................
32
3.5.3
ASPIRIN
AND
CLOPIDOGREL
INTAKE
.......................................................................
32
3.5.4
TARGET
LESION
REVASCULARIZATION
...................................................................
34
3.5.5
PROCEDURE-RELATED,
DEVICE-RELATED
OR
SERIOUS
ADVERSE
EVENTS
......................
35
3.5.6
PATIENT
DEATHS
...............................................................................................
36
3.5.7
PEAK
SYSTOLIC
VELOCITY
RATIO
AND
DUPLEX
DERIVED
PRIMARY
PATENCY
...............
36
3.5.8
ANKIE
BRACHIAL
INDEX
......................................................................................
37
3.6
SYMPTOM
DEVELOPMENT.......................................................................................
38
3.6.1
QUALITY
OF
LIFE
MEASURED
BY
EQ-5D
AT
BASELINE
AND
FOLLOW-UP......................
38
3.6.2
CHANGES
IN
RUTHERFORD
CLASSIFICATION
............................................................
40
3.6.3
WALKING
IMPAIRMENT
QUESTIONNAIRE................................................................
42
4.
DISCUSSION.........................................................................................................
45
4.1
OVERVIEW...............................................................................................................
45
4.2
PRIMARY
PATENCY
AND
TLR
RATE
..........................................................................
45
4.2.1
PROCEDURAL
SUCCESS
AND
BAILOUT
STENTING........................................................
47
4.2.2
MAJOR
ADVERSE
EVENTS....................................................................................
48
4.3
CLINICAL
DEVELOPMENT
..........................................................................................
48
4.3.1
ANKIE
BRACHIAL
INDEX
......................................................................................
48
4.3.2
RUTHERFORD
CLINICAL
CATEGORY..........................................................................
49
4.3.3
EQ-5DWIQ
....................................................................................................
50
4.4
PATIENT
POPULATION
...............................................................................................
51
4.5
LIMITATIONS
..........................................................................................................
52
5.
SUMMARY
...........................................................................................................
53
6.
ZUSAMMENFASSUNG
..........................................................................................
54
7.
LITERATURE
...........................................................................................................
55
8.
LEBENSLAUF
.........................................................................................................
63
9.
EIDESSTATTLICHE
VERSICHERUNG
..........................................................................
64
10.
DANKSAGUNG
......................................................................................................
65
|
| adam_txt |
INDEX
1.
INTRODUCTION
.
1
1.1
SUBJECT
MATTER
.
1
1.2
PERIPHERAL
ARTERY
DISEASE
(PAD)
.
1
1.2.1
DISEASE
OVERVIEW
.
1
1.2.2
ETIOLOGY
.
2
1.2.3
RISK
FACTORS
.
2
1.2.4
PAD
AND
THE
SUPERFICIAL
FEMORAL
AND
POPLITEAL
ARTERY
.
3
1.2.4.1
SUPERFICIAL
FEMORAL
ARTERY
AND
POPLITEAL
ARTERY
ANATOMY
.
4
1.2.4.2
ADDITIONAL
FACTORS
IN
THE
ONSET
AND
TREATMENT
OF
PAD
IN
THE
SFA
.
4
1.2.5
THERAPY
.
5
1.2.5.1
REDUCTION
OF
RISK
FACTORS.
5
1.2.5.2
DRUG
THERAPY
.
6
1.2.5.3
EXERCISE
TRAINING
.
6
1.2.5.4
OPERATIONAL
/
BYPASS
THERAPY
.
7
1.2.5.5
CATHETER-BASED
INTERVENTIONS
.
7
1.2.5.5.1
DRUG
COATED
BALLOON
.
8
1.2.5.5.2
PHOTO-ABLATIVE
ATHERECTOMY
.
8
1.3
CLASSIFICATION
SYSTEMS
USED
FOR
PAD
AND
IN-STENT
RESTENOSIS
.
9
1.3.1
FONTAINE
CLASSIFICATION.
9
1.3.2
RUTHERFORD-BECKER
CLASSIFICATION
.
10
1.3.3
TASC
II
CLASSIFICATION
.
11
1.3.4
TOSAKA
CLASSIFICATION
.
11
2.
MATERIALS
AND
METHODS
.
12
2.1
STUDY
DESIGN.
12
2.2
STUDY
PURPOSE
.
12
2.3
STUDY
OUTCOME
.
12
2.3.1
PRIMARY
OUTCOME
.
12
2.3.2
SECONDARY
OUTCOMES
.
13
2.4
SELECTION
OF
PATIENTS
.
14
2.4.1
INCLUSION
/
EXCLUSION
CRITERIA.
14
2.4.2
RANDOMIZATION.
15
2.5
PRE-PROCEDURE.
15
2.6
PROCEDURE
.
16
2.6.1
TARGET
/
NON-TARGET
LESION.
16
2.6.2
EXCIMER
LASER
PHOTOABLATION
AND
DCB
GROUP
PROCEDURES.
16
2.6.3
DCB
GROUP
PROCEDURES
.
18
2.6.4
ADJUNCTIVE
PROCEDURES
.
18
2.6.5
PROCEDURE
COMPLETION
.
18
2.6.6
MEDICAL
ANTICOAGULANT
/
ANTIPLATELET
THERAPY
.
18
2.6.7
FOLLOW-UP
REQUIREMENTS
.
19
2.6.8
UNSCHEDULED
REINTERVENTION.
19
2.6.9
TERMINATION
OF
PARTICIPATION
/
SUBJECT
WITHDRAWAL
.
20
2.6.10
ADVERSE
EVENTS.
20
2.7
DATA
RECORDED
.
21
3.
RESULTS
.
22
3.1
ENROLMENT
STATUS
.
22
3.2
PATIENT
CHARACTERISTICS.
23
3.2.1
CARDIOVASCULAR
RISK
FACTORS
AT
BASELINE
.
24
3.2.2
COMORBIDITIES
AT
BASELINE
.
25
3.3
LESION
CHARACTERISTICS
.
26
3.3.1
PREVIOUS
TREATMENT
FOR
PAD
ON
TARGET
VESSEL
.
27
3.3.2
LESION
CHARACTERISTICS:
DEGREE
OF
STENOSIS
PRE-TREATMENT.
27
3.3.3
POST-TREATMENT
LESION
CHARACTERISTICS.
28
3.3.4
CALCIFICATION
OF
TARGET
VESSEL
AT
BASELINE
.
29
3.3.5
LESION
LENGTH
AT
BASELINE
.
30
3.4
PROCEDURAL
VARIABLES
.
30
3.5
POST-PROCEDURAL
RESULTS
.
31
3.5.1
PRIMARY
ENDPOINT
-
TARGET
LESION
PERCENT
STENOSIS
AT
1
YEAR
.
31
3.5.2
LATE
LUMEN
LOESS
AT
12
MONTHS
.
32
3.5.3
ASPIRIN
AND
CLOPIDOGREL
INTAKE
.
32
3.5.4
TARGET
LESION
REVASCULARIZATION
.
34
3.5.5
PROCEDURE-RELATED,
DEVICE-RELATED
OR
SERIOUS
ADVERSE
EVENTS
.
35
3.5.6
PATIENT
DEATHS
.
36
3.5.7
PEAK
SYSTOLIC
VELOCITY
RATIO
AND
DUPLEX
DERIVED
PRIMARY
PATENCY
.
36
3.5.8
ANKIE
BRACHIAL
INDEX
.
37
3.6
SYMPTOM
DEVELOPMENT.
38
3.6.1
QUALITY
OF
LIFE
MEASURED
BY
EQ-5D
AT
BASELINE
AND
FOLLOW-UP.
38
3.6.2
CHANGES
IN
RUTHERFORD
CLASSIFICATION
.
40
3.6.3
WALKING
IMPAIRMENT
QUESTIONNAIRE.
42
4.
DISCUSSION.
45
4.1
OVERVIEW.
45
4.2
PRIMARY
PATENCY
AND
TLR
RATE
.
45
4.2.1
PROCEDURAL
SUCCESS
AND
BAILOUT
STENTING.
47
4.2.2
MAJOR
ADVERSE
EVENTS.
48
4.3
CLINICAL
DEVELOPMENT
.
48
4.3.1
ANKIE
BRACHIAL
INDEX
.
48
4.3.2
RUTHERFORD
CLINICAL
CATEGORY.
49
4.3.3
EQ-5DWIQ
.
50
4.4
PATIENT
POPULATION
.
51
4.5
LIMITATIONS
.
52
5.
SUMMARY
.
53
6.
ZUSAMMENFASSUNG
.
54
7.
LITERATURE
.
55
8.
LEBENSLAUF
.
63
9.
EIDESSTATTLICHE
VERSICHERUNG
.
64
10.
DANKSAGUNG
.
65 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Lerke, Frederik |
| author_GND | (DE-588)1226864422 |
| author_facet | Lerke, Frederik |
| author_role | aut |
| author_sort | Lerke, Frederik |
| author_variant | f l fl |
| building | Verbundindex |
| bvnumber | BV047335981 |
| ctrlnum | (OCoLC)1245375843 (DE-599)KXP1747969346 |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02781nam a2200493 c 4500</leader><controlfield tag="001">BV047335981</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210617s2021 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,H04</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1226896227</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1245375843</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1747969346</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lerke, Frederik</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1226864422</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie</subfield><subfield code="b">= Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion</subfield><subfield code="c">vorgelegt 2020 von Frederik Lerke</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Freiburg im Breisgau</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">65 Blätter</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">30 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Albert-Ludwigs-Universität Freiburg im Breisgau</subfield><subfield code="d">2020</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">1\p</subfield><subfield code="a">Arterie</subfield><subfield code="0">(DE-588)4003066-0</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">2\p</subfield><subfield code="a">Oberschenkelknochen</subfield><subfield code="0">(DE-588)4172282-6</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">3\p</subfield><subfield code="a">Restenose</subfield><subfield code="0">(DE-588)4254140-2</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">4\p</subfield><subfield code="a">Angioplastie</subfield><subfield code="0">(DE-588)4134337-2</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">5\p</subfield><subfield code="a">Laserangioplastie</subfield><subfield code="0">(DE-588)4201389-6</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">https://d-nb.info/1226896227/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032738502&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032738502</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,21112</subfield><subfield code="d">20210302</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,17098</subfield><subfield code="d">20210302</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,14789</subfield><subfield code="d">20210302</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,14412</subfield><subfield code="d">20210302</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,10975</subfield><subfield code="d">20210302</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV047335981 |
| illustrated | Illustrated |
| index_date | 2024-07-03T17:32:41Z |
| indexdate | 2024-07-10T09:09:19Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032738502 |
| oclc_num | 1245375843 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 65 Blätter Illustrationen, Diagramme 30 cm |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| record_format | marc |
| spelling | Lerke, Frederik Verfasser (DE-588)1226864422 aut Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion vorgelegt 2020 von Frederik Lerke Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion Freiburg im Breisgau [2021] 65 Blätter Illustrationen, Diagramme 30 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Albert-Ludwigs-Universität Freiburg im Breisgau 2020 1\p Arterie (DE-588)4003066-0 gnd 2\p Oberschenkelknochen (DE-588)4172282-6 gnd 3\p Restenose (DE-588)4254140-2 gnd 4\p Angioplastie (DE-588)4134337-2 gnd 5\p Laserangioplastie (DE-588)4201389-6 gnd (DE-588)4113937-9 Hochschulschrift gnd-content B:DE-101 application/pdf https://d-nb.info/1226896227/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032738502&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p aepgnd 0,21112 20210302 DE-101 https://d-nb.info/provenance/plan#aepgnd 2\p aepgnd 0,17098 20210302 DE-101 https://d-nb.info/provenance/plan#aepgnd 3\p aepgnd 0,14789 20210302 DE-101 https://d-nb.info/provenance/plan#aepgnd 4\p aepgnd 0,14412 20210302 DE-101 https://d-nb.info/provenance/plan#aepgnd 5\p aepgnd 0,10975 20210302 DE-101 https://d-nb.info/provenance/plan#aepgnd |
| spellingShingle | Lerke, Frederik Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion 1\p Arterie (DE-588)4003066-0 gnd 2\p Oberschenkelknochen (DE-588)4172282-6 gnd 3\p Restenose (DE-588)4254140-2 gnd 4\p Angioplastie (DE-588)4134337-2 gnd 5\p Laserangioplastie (DE-588)4201389-6 gnd |
| subject_GND | (DE-588)4003066-0 (DE-588)4172282-6 (DE-588)4254140-2 (DE-588)4134337-2 (DE-588)4201389-6 (DE-588)4113937-9 |
| title | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| title_alt | Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| title_auth | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| title_exact_search | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| title_exact_search_txtP | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| title_full | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion vorgelegt 2020 von Frederik Lerke |
| title_fullStr | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion vorgelegt 2020 von Frederik Lerke |
| title_full_unstemmed | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion vorgelegt 2020 von Frederik Lerke |
| title_short | Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie |
| title_sort | vergleich der laserangioplastie plus medikamentenbeschichtete ballonangioplastie dcb versus alleinige dcb angioplastie bei in stent restenosen verschlussen der femoropoplitealen arterie laserangioplasty plus drug coated balloon dcb angioplasty vs plain dcb angioplasty for treatment of femoro popliteal in stent restenosis and occlusion |
| title_sub | = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion |
| topic | 1\p Arterie (DE-588)4003066-0 gnd 2\p Oberschenkelknochen (DE-588)4172282-6 gnd 3\p Restenose (DE-588)4254140-2 gnd 4\p Angioplastie (DE-588)4134337-2 gnd 5\p Laserangioplastie (DE-588)4201389-6 gnd |
| topic_facet | Arterie Oberschenkelknochen Restenose Angioplastie Laserangioplastie Hochschulschrift |
| url | https://d-nb.info/1226896227/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032738502&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT lerkefrederik vergleichderlaserangioplastieplusmedikamentenbeschichteteballonangioplastiedcbversusalleinigedcbangioplastiebeiinstentrestenosenverschlussenderfemoropoplitealenarterielaserangioplastyplusdrugcoatedballoondcbangioplastyvsplaindcbangioplastyfortreatmentoffe AT lerkefrederik laserangioplastyplusdrugcoatedballoondcbangioplastyvsplaindcbangioplastyfortreatmentoffemoropoplitealinstentrestenosisandocclusion |
There is no print copy available.
Indexes